Eagle Global Advisors’s Quest Diagnostics DGX Stock Holding History

Eagle Global Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,870	Closed	-$208K	–	287
2017 Q2	$208K	Buy	+1,870	New	+$198K	0.01%	371

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Eagle Global Advisors's DGX Position: Q3 2017 in Review

Eagle Global Advisors sold out of Quest Diagnostics (DGX) in Q3 2017, closing a stake of 1,870 shares — an estimated $208K sold.

Eagle Global Advisors first reported a position in DGX in Q2 2017 and held it in 1 quarter. The position peaked at $208K in Q2 2017. 616 funds tracked by Wall St. Rank hold DGX as of Q3 2017.

Eagle Global Advisors reported no remaining Quest Diagnostics position as of Q3 2017 after selling out during the quarter.
Eagle Global Advisors sold 1,870 Quest Diagnostics shares in Q3 2017, an estimated $208K.
Eagle Global Advisors first reported a position in Quest Diagnostics in Q2 2017 and held it in 1 quarter.
Eagle Global Advisors's Quest Diagnostics position peaked at $208K in Q2 2017.
616 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2017.

Based on Eagle Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.